Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 60


Effective Cessation Strategies for Smokers with Schizophrenia.

Evins AE, Cather C.

Int Rev Neurobiol. 2015;124:133-47. doi: 10.1016/bs.irn.2015.08.001. Epub 2015 Sep 14.


The NAVIGATE Program for First-Episode Psychosis: Rationale, Overview, and Description of Psychosocial Components.

Mueser KT, Penn DL, Addington J, Brunette MF, Gingerich S, Glynn SM, Lynde DW, Gottlieb JD, Meyer-Kalos P, McGurk SR, Cather C, Saade S, Robinson DG, Schooler NR, Rosenheck RA, Kane JM.

Psychiatr Serv. 2015 Jul;66(7):680-90. doi: 10.1176/ Epub 2015 Mar 16.


Treatment of tobacco use disorders in smokers with serious mental illness: toward clinical best practices.

Evins AE, Cather C, Laffer A.

Harv Rev Psychiatry. 2015 Mar-Apr;23(2):90-8. doi: 10.1097/HRP.0000000000000063.


A randomized placebo-controlled pilot study of pravastatin as an adjunctive therapy in schizophrenia patients: effect on inflammation, psychopathology, cognition and lipid metabolism.

Vincenzi B, Stock S, Borba CP, Cleary SM, Oppenheim CE, Petruzzi LJ, Fan X, Copeland PM, Freudenreich O, Cather C, Henderson DC.

Schizophr Res. 2014 Nov;159(2-3):395-403. doi: 10.1016/j.schres.2014.08.021. Epub 2014 Sep 26.


Evolving illness, shifting perspectives: childhood psychosis through the lenses of family therapy and individual therapy.

Greene DI, Spencer AE, Pridgen BC, Cather C, Ablon S.

Harv Rev Psychiatry. 2013 Sep-Oct;21(5):259-68. doi: 10.1097/HRP.0b013e3182a75c7a. No abstract available.


Maintenance treatment with varenicline for smoking cessation in patients with schizophrenia and bipolar disorder: a randomized clinical trial.

Evins AE, Cather C, Pratt SA, Pachas GN, Hoeppner SS, Goff DC, Achtyes ED, Ayer D, Schoenfeld DA.

JAMA. 2014 Jan 8;311(2):145-54. doi: 10.1001/jama.2013.285113.


Long-term outcomes of a randomized trial of integrated skills training and preventive healthcare for older adults with serious mental illness.

Bartels SJ, Pratt SI, Mueser KT, Forester BP, Wolfe R, Cather C, Xie H, McHugo GJ, Bird B, Aschbrenner KA, Naslund JA, Feldman J.

Am J Geriatr Psychiatry. 2014 Nov;22(11):1251-61. doi: 10.1016/j.jagp.2013.04.013. Epub 2013 Aug 14.


An Open Trial of Relapse Prevention Therapy for Smokers With Schizophrenia.

Cather C, Dyer MA, Burrell HA, Hoeppner B, Goff DC, Evins AE.

J Dual Diagn. 2013;9(1):87-93.


Varenicline for Smoking Cessation in Schizophrenia: Safety and Effectiveness in a 12-Week, Open-Label Trial.

Pachas GN, Cather C, Pratt SA, Hoeppner B, Nino J, Carlini SV, Achtyes ED, Lando H, Mueser KT, Rigotti NA, Goff DC, Evins AE.

J Dual Diagn. 2012;8(2):117-125. Epub 2012 May 11.


A randomized controlled trial of family intervention for co-occurring substance use and severe psychiatric disorders.

Mueser KT, Glynn SM, Cather C, Xie H, Zarate R, Smith LF, Clark RE, Gottlieb JD, Wolfe R, Feldman J.

Schizophr Bull. 2013 May;39(3):658-72. doi: 10.1093/schbul/sbr203. Epub 2012 Jan 26.


D-cycloserine facilitation of cognitive behavioral therapy for delusions in schizophrenia.

Gottlieb JD, Cather C, Shanahan M, Creedon T, Macklin EA, Goff DC.

Schizophr Res. 2011 Sep;131(1-3):69-74. doi: 10.1016/j.schres.2011.05.029. Epub 2011 Jun 30.


Effects of modafinil on weight, glucose and lipid metabolism in clozapine-treated patients with schizophrenia.

Henderson DC, Freudenreich O, Borba CP, Wang X, Copeland PM, Macklin E, Fan X, Cather C, Goff DC.

Schizophr Res. 2011 Aug;130(1-3):53-6. doi: 10.1016/j.schres.2011.04.009. Epub 2011 May 11.


Neurocognition and social skill in older persons with schizophrenia and major mood disorders: An analysis of gender and diagnosis effects.

Mueser KT, Pratt SI, Bartels SJ, Forester B, Wolfe R, Cather C.

J Neurolinguistics. 2010 May;23(3):297-317.


Morgellons disease, or antipsychotic-responsive delusional parasitosis, in an HIV patient: beliefs in the age of the Internet.

Freudenreich O, Kontos N, Tranulis C, Cather C.

Psychosomatics. 2010 Nov-Dec;51(6):453-7. doi: 10.1176/appi.psy.51.6.453. No abstract available.


Randomized trial of social rehabilitation and integrated health care for older people with severe mental illness.

Mueser KT, Pratt SI, Bartels SJ, Swain K, Forester B, Cather C, Feldman J.

J Consult Clin Psychol. 2010 Aug;78(4):561-73. doi: 10.1037/a0019629.


Dietary saturated fat intake and glucose metabolism impairments in nondiabetic, nonobese patients with schizophrenia on clozapine or risperidone.

Henderson DC, Sharma B, Fan X, Copeland PM, Borba CP, Freudenreich O, Cather C, Evins AE, Goff DC.

Ann Clin Psychiatry. 2010 Feb;22(1):33-42.


Modafinil for clozapine-treated schizophrenia patients: a double-blind, placebo-controlled pilot trial.

Freudenreich O, Henderson DC, Macklin EA, Evins AE, Fan X, Cather C, Walsh JP, Goff DC.

J Clin Psychiatry. 2009 Dec;70(12):1674-80. doi: 10.4088/JCP.08m04683. Epub 2009 Aug 11.


Waist circumference is the best anthropometric predictor for insulin resistance in nondiabetic patients with schizophrenia treated with clozapine but not olanzapine.

Henderson DC, Fan X, Sharma B, Copeland PM, Borba CP, Freudenreich O, Cather C, Evins AE, Goff DC.

J Psychiatr Pract. 2009 Jul;15(4):251-61. doi: 10.1097/01.pra.0000358312.99233.ef.


Cognitive behavioral therapy of negative symptoms.

Perivoliotis D, Cather C.

J Clin Psychol. 2009 Aug;65(8):815-30. doi: 10.1002/jclp.20614.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk